You are here: All Products  > Pfizer Gains China Approval of Drug for Kinase-Specific Lung Cancer

Pfizer Gains China Approval of Drug for Kinase-Specific Lung Cancer

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products